MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-23-2026
Renalytix AI plc Current Ratio 2011-2026 | RNLX
Annual Current Ratio Renalytix AI plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.504 | 1.29 | 2.57 | 11 | 4.2 | 8.44 | 0.186 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11 | 0.186 | 4.03 |
Quarterly Current Ratio Renalytix AI plc
| 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.3 | 0.44 | 0.59 | 0.93 | 0.59 | 0.93 | 1.29 | 1.83 | 1.41 | 1.95 | 2.57 | 2.95 | 6.35 | - | 11 | - | - | - | 4.2 | - | - | - | 8.44 | - | - | - | 0.19 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11 | 0.19 | 2.71 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
Fulgent Genetics
FLGT
|
11.4 | $ 18.89 | -3.13 % | $ 581 M | USA |
 |
Celcuity
CELC
|
1.27 | $ 89.34 | -3.39 % | $ 4.18 B | USA |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
6.01 | $ 5.63 | -2.34 % | $ 7.49 M | USA |
 |
Castle Biosciences
CSTL
|
5.37 | $ 21.25 | -1.62 % | $ 616 M | USA |
 |
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
0.338 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
0.953 | $ 128.77 | -3.22 % | $ 16.1 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
3.75 | $ 22.6 | -2.25 % | $ 1.2 B | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 | $ 149.81 | -1.96 % | $ 11.7 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
2.95 | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
Illumina
ILMN
|
6.69 | $ 162.31 | -3.42 % | $ 25.2 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.42 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
1.96 | $ 103.33 | 0.5 % | $ 6.97 B | USA |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 185.1 | -0.37 % | $ 9.17 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
1.3 | $ 454.92 | -0.82 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
0.994 | $ 1 162.75 | -1.5 % | $ 24 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
2.6 | $ 11.12 | -1.68 % | $ 1.42 B | USA |
 |
National Research Corporation
NRC
|
1.12 | $ 19.87 | 0.61 % | $ 445 M | USA |
 |
Myriad Genetics
MYGN
|
2.09 | $ 4.66 | -0.75 % | $ 432 M | USA |
 |
Natera
NTRA
|
3.5 | $ 217.81 | -1.93 % | $ 29.8 B | USA |
 |
Personalis
PSNL
|
4.58 | $ 11.27 | -6.83 % | $ 1.01 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.69 | $ 26.17 | 0.69 % | $ 24.8 B |  Niderland |
 |
Senseonics Holdings
SENS
|
1.94 | $ 6.83 | -2.57 % | $ 285 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
4.96 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
3.23 | $ 2.22 | 3.27 % | $ 5.1 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 265.1 | 1.58 % | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
3.8 | $ 71.05 | -3.9 % | $ 4.25 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.92 | $ 474.65 | -1.53 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.746 | $ 0.71 | 3.79 % | $ 255 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.51 | $ 8.93 | -2.14 % | $ 1.94 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 199.14 | 1.54 % | $ 22.1 B | USA |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
2.02 | $ 369.99 | -1.72 % | $ 22 B | USA |